Integrated Research share price rises on record FY19 result

The Integrated Research Ltd (ASX: IRI) share price has jumped more than 5% in early trade after the software company reported a record full-year result

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Integrated Research Limited (ASX: IRI) share price has jumped in early trade after the software company reported a record full-year result prior to market open.

What did Integrated Research announce?

For the year ended 30 June 2019 (FY19), Integrated Research announced that it had passed key milestones in hitting $100 million in revenue and $20 million in profit for the first time.

The Aussie performance management software group increased net profit after tax (NPAT) by 14% on the prior corresponding period (pcp) to $21.9 million, at the top end of its July 2019 guidance range.

The strong profit result was made possible by a 19% increase in new licence sales throughout the year, which saw revenue surge 11% on pcp to $100.8 million.

The biggest contributor to revenue was the group's Unified Communications and Contact Centre segment, which comprised roughly half of all earnings despite a 7% decrease on pcp.

Payments revenue surged 92%, albeit off a low base, to $16 million for the year largely thanks to a combination of new and renewal business, while the company's Infrastructure segments increased by 28% to $26.3 million.

However, management is not resting on its laurels following the strong result, with gross spending on research and development maintained at 19% of revenue while Integrated Research's earnings before interest, tax, depreciation and amortisation (EBITDA) remains at 40%.

Positively for shareholders, Integrated Research's net profit after tax (NPAT) margin edged higher to 22% (versus 21% in pcp) as NPAT surged 12% higher for the year.

On the dividend side, Integrated Research directors declared a fully franked, interim dividend of 3.75 cents per share (cps), which takes the company's full-year dividend to 7.25 cps (versus 6.5 cps in pcp).

Foolish takeaway

All in all I think this morning's result was a positive one for Integrated Research and its shareholders, underscored by the strong profit numbers and margins.

Investors look like they tend to agree, with the Integrated Research share price trading more than 5% higher at one point in morning trade and currently trading 3.86% higher at time of writing. Overall, the shares have climbed nearly 60% higher since the start of the year.

Kenneth Hall has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Integrated Research Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »